Francis Knuettel
Independent DirectorMr. Francis Knuettel, II, M.B.A., also known as Frank, is Chief Financial Officer of OS Therapies Incorporated from September 29, 2026. He is Independent Director at Endovia Health Sciences, Inc. (formerly known as Splash Beverage Group, Inc.) since April 27, 2026. He is Chief Financial Officer of NVN Liquidation, Inc. from 2025. He is Director at Beeline Loans, Inc. since 2025. He is Independent Director of Beeline Holdings, Inc. from May 14, 2025. Mr. Knuettel has executive leadership experience across dynamic, early-stage public companies in the technology and life sciences sectors. He served as the CFO of Pelthos Therapeutics following its merger with Channel Therapeutics Corporation, where he was the CEO. Known for his operational discipline and M&A acumen, Mr. Knuettel has helped companies scale aggressively deep capital markets knowledge, a proven ability to lead and scale businesses and transactional experience across more than 15 M&A deals. Throughout his career, Mr. Knuettel has raisedamount in public and private capital and has held leadership roles at multiple high-growth companies. Mr. Knuettel is Executive Chairman & Interim Chief Executive Officer of Innovation1 Biotech Inc. from November 7, 2024. He served as Director at VisitIQ Corp. (formerly known as Capstone Technologies Group, Inc.) since November 2023. He serves as Chief Financial Officer at Semper Paratus Acquisition Corporation since June 7, 2023. He joined Pelthos Therapeutics Inc. (formerly known as Channel Therapeutics Corporation) on June 10, 2022. He was Treasurer and Secretary of Pelthos Therapeutics Inc. (formerly known as Channel Therapeutics Corporation) (formerly known as Chromocell Therapeutics Corporation) since June 2022 until July 1, 2025 and served as its Chief Strategy Officer and served as its Chief Executive Officer since March 13, 2024 until July 1, 2025 and served as its Chief Financial Officer since June 2022 until April 10, 2026. He was the President of Pelthos Therapeutics Inc. (formerly known as Channel Therapeutics Corporation) (formerly known as Chromocell Therapeutics Corporation) until July 1, 2025 and was its Director since August 2024 until July 1, 2025. He was the Interim Chief Executive Officer at Pelthos Therapeutics Inc. (formerly known as Channel Therapeutics Corporation) (formerly known as Chromocell Therapeutics Corporation) since July 19, 2023 until March 13, 2024. He served as an Independent Director at 180 Life Sciences Corp. since July 2, 2021 until December 17, 2023. He served as Chief Financial Officer at OceanTech Acquisitions I Corp. since March 13, 2023. He serves as an Independent Director at Murphy Canyon Acquisition Corp. He served as an Independent Director at Relativity Acquisition Corp. since February 10, 2022 until 2025. Mr. Knuettel served as the Chief Executive Officer at Unrivaled Brands, Inc. (formerly known as Terra Tech Corp.) since March 02, 2021 until March 13, 2022 and also served as Secretary since February 01, 2021 until April 2022. He served as President of Unrivaled Brands, Inc. since March 2, 2021 until March 13, 2022. He served as a Director at Unrivaled Brands, Inc. (formerly known as Terra Tech Corp.) since December 11, 2020 until April 2022. He serves as a Director of Sanatio BioScience Corp since September 2020. He served as the President of Unrivaled Brands, Inc. (formerly known as Terra Tech Corp.) since December 15, 2020 until July 27, 2021 and served as its Interim Chief Executive Officer and President from December 15, 2020 till March 02, 2021. He serves as Chief Strategy Officer of Growforce Inc. (also known as Growforce Holdings Inc.) since December 2018. He served as a Director at SCWorx Corp. since February 01, 2019 until December 31, 2019. Mr. Knuettel served as a Director of Capital and Advisory at Viridian Capital Advisors from June 2020 to January 2021. He joined Veridian from One Cannabis Group ("OCG"). At OCG, Mr. Knuettel served as the Chief Financial Officer from June 2019 to January 2021, where he was responsible for all finance and accounting management. He served as Chief Strategy Officer of MJardin Group, Inc. since January 2019 to June 2019. He served as Chief Financial Officer of MJardin Group, Inc. from August 2018 to January 2019, where he led its IPO on the Canadian Securities Exchange. Prior to MJardin, Mr. Knuettel held numerous CFO and CEO positions at early-stage companies where he had significant experience both building and restructuring businesses. Prior to Mjardin Group, he served as the Chief Financial Officer of Aqua Metals, Inc. since April 16, 2018 until August 13, 2018. He serves as the Managing Member of Camden Capital LLC since 2007. Mr. Knuettel served as the Chief Financial Officer of Marathon Patent Group, Inc. from May 15, 2014 to April 22, 2018 and served as its Secretary since March 2014 until April 22, 2018. He served as the Chief Financial Officer of IP Commerce Inc. from 2007 to 2013. Mr. Knuettel was responsible for overall financial management, including further development of its infrastructure to accommodate its accelerated growth at of IP Commerce Inc. Mr. Knuettel served as Consultant of InfoSearch Media Inc. since June 11, 2007. He founded IMC Semiconductor, Inc. and served as its Chief Financial Officer and Vice President of Operations. Prior to joining IP Commerce, he served as Chief Financial Officer of Infosearch Media Inc. (formerly Mac Worldwide Inc.) from March 8, 2005 to June 11, 2007 and served as Principal Accounting Officer until June 11, 2007. Mr. Knuettel served as Managing Director and Chief Financial Officer of Greyhound IP LLC. He served as Secretary of InfoSearch Media Inc. from March 23, 2007 to June 11, 2007 and served as Vice President until June 2007. Prior to joining InfoSearch Media, he co-founded Internet Machines Corporation, where he held several positions, including Interim Chief Executive Officer, Chief Financial Officer and Vice President of Operations. Before founding Internet Machines, Mr. Knuettel served as Chief Financial Officer and Chief Operating Officer of Viking Systems, where he was responsible for fundraising and building a strong financial foundation for Viking Systems in preparation for significant market growth. Prior to that, he served as Vice President and Chief Financial Officer of Fightertown Entertainment, Inc. in Lake Forest, California where he was responsible for the development of its strategic and expansion plans as well as all financial operations. He held various roles in finance and strategy. Mr. Knuettel held several senior financial positions from 1999 to 2007. Mr. Knuettel served as Chief Financial Officer of Troika Networks, Inc. since January 2005. Mr. Knuettel has decades of experience in working with and advising public and private companies on financial management and controls, M&A, capital markets transactions and operating and financial restructurings. He served as the Chairman of Spindle, Inc. from Jun
Positions
- Company NameEndovia Health Sciences, Inc.Stock CodeEDVAPositionIndependent Director
- Company NameOS Therapies IncorporatedStock CodeOSTXPositionChief Financial OfficerColleagues
- PAPaul A. RomnessFounder, Chairman, President & CEO
- RGRobert G. PetitChief Medical Officer & Chief Scientific Officer
- FKFrancis KnuettelChief Financial Officer
- JDJack DollChief of Staff
- GEGerald E. CommissiongChief Business Officer
- JCJohn CiccioIndependent Director
- TFTheodore F. SearchIndependent Director
- JWJutta WannerMember of Antibody Drug Conjugate (ADC) Advisory Board
- OEOlivia EggeMember of Patient Advocacy Advisory Board
- Company NameBeeline Holdings, Inc.Stock CodeBLNEPositionIndependent DirectorColleagues
- NRNicholas R. LiuzzaChairman of the Board & CEO
- CRChristopher R. MoeChief Financial Officer
- TMTiffany MiltonChief Accounting Officer
- JNJessica N. KennedyChief Operating Officer
- CSCameron SlaboszChief Technology Officer
- JDJoseph David FreedmanIndependent Director
- JSJoseph Stevens CaltabianoIndependent Director
- FKFrancis KnuettelIndependent Director
- SRStephen RomanoIndependent Director
